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Background: Understanding how Q226E and 
V280M produce tonic activation may reveal how 
glycine receptors activate. 
Results: Q226E generates an attraction between 
first and second transmembrane domains. V280M 
separates first and third transmembrane domains. 
Conclusion: We propose either movement can 
initiate activation.  
Significance: Comparison with X-ray structures of 
bacterial Cys-loop receptors suggests these 
activation mechanisms apply broadly across the 
receptor family. 
 
ABSTRACT 
   Pentameric ligand-gated ion channels 
(pLGICs) mediate numerous physiological 
processes and are therapeutic targets for a wide 
range of clinical indications. Elucidating the 
structural differences between their closed and 
open states may help in designing improved 
drugs that bias receptors towards the desired 
conformational state. We recently showed that 
two new hyperekplexia mutations, Q226E and 
V280M, induced spontaneous activity in α1 
glycine receptors. Q226, located near the top of 
TM1, is closely apposed to R271 at the top of 
TM2 in the neighbouring subunit.  Using 
mutant cycle analysis we inferred that Q226E 
induces activation via an enhanced electrostatic 
attraction to R271. This would tilt the top of 
TM2 towards TM1 and hence away from the 
pore axis to open the channel. We also 
concluded that the increased side chain volume 
of V280M, in the TM2-TM3 loop, exerts a steric 
repulsion against I225 at the top of TM1 in the 
neighbouring subunit. We infer that this steric 
repulsion would tilt the top of TM3 radially 
outwards against the stationary TM1 and thus 
provide space for TM2 to relax away from the 
pore axis to create an open channel. Because the 
transmembrane domain movements inferred 
from this functional analysis are consistent with 
the structural differences evident in the X-ray 
atomic structures of closed and open state 
bacterial pLGICs, we propose that the model of 
pLGIC activation as outlined here may be 
broadly applicable across the eukaryotic pLGIC 
receptor family.  
   Glycine receptors (GlyRs), which belong to the 
family of pentameric ligand-gated ion channel 
(pLGIC) receptors, mediate inhibitory 
neurotransmission in the spinal cord, brainstem and 
retina (1,2). In humans, four α GlyR subunits (α1 – 
α4) and a single β subunit are known	   (3). GlyRs 
express as α homomers or as αβ heteromers. 
However, synaptic GlyRs are thought to exist 
predominantly as αβ heteromers as the β subunit is 
required for synaptic clustering via the cytoplasmic 
scaffolding protein, gephyrin (4,5). Each GlyR 
subunit contains an extracellular domain (ECD) 
harbouring a ligand-binding site and a 
transmembrane domain (TMD) formed by four 
membrane-spanning α-helices (termed TM1 – 
TM4) that are connected by flexible loops	   (6-9). 
The TM2 domains line the central ion-conducting 
pore with the other domains arranged 
concentrically around it providing an interface 
between the hydrophilic pore and the hydrophobic 
membrane.  
    Several pLGIC receptors, notably the nicotinic 
acetylcholine receptor and the GABA type-A 
receptor (GABAAR), have long been important 
therapeutic targets, and the GlyR has recently 
emerged as a potential target for indications 
including inflammatory pain sensitisation (10-12), 
opioid-induced breathing depression (13), tinnitus 
(14) and temporal lobe epilepsy (15). It is 
important to resolve the mechanisms by which the 
structure of pLGIC receptors changes between the 
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closed and open states in order to design new drugs 
that bias the receptor towards the desired 
conformation.  
    Human hereditary hyperekplexia (or startle 
disease) is most commonly caused by missense or 
nonsense mutations that disrupt the function of the 
α1 GlyR subunit (16,17). Analysis of the effects of 
hyperekplexia mutations have provided several 
important insights into GlyR structure and function 
(2). We recently characterized two new 
hyperekplexia mutations, Q226E and V280M, that 
each resulted in spontaneous activity in both α1 
homomeric and α1β heteromeric GlyRs	  (18). Q226 
is located near the top of TM1 whereas V280 is 
located in the extracellular TM2-TM3 loop. Both 
sites are thus located near the ECD-TMD interface 
where agonist-induced conformational changes are 
transduced, via the movement of TM2 α-helices, 
into channel opening (6-9). In this study, we 
employed a variety of functional approaches to 
elucidate the molecular mechanisms by which the 
Q226E and V280M mutations induce spontaneous 
channel openings with the aim of characterizing 
TMD movements underlying channel activation.  
EXPERIMENTAL PROCEDURES  
Molecular biology - Mutations were introduced 
into the human α1 GlyR using the QuikChange 
site-directed mutagenesis kit (Stratagene, UK) and 
confirmed by direct sequencing of the entire 
transgene-coding region.  
Cell culture - HEK AD293 cells were cultured in 
Dulbecco’s modified Eagle medium supplemented 
with 10 % Fetal Bovine Serum, 30 U/ml penicillin 
and 30 µg/ml streptomycin, transiently transfected 
via the calcium-phosphate method with wild type 
and mutated cDNAs and used in experiments two 
to three days after transfection. 
Fluorescence-based imaging - Experiments were 
performed on HEK AD293 cells and the α1 GlyR 
and the YFP-I152L plasmid DNA were co-
transfected in equal amounts. When the 
transfection was terminated 16 h later by rinsing 
with fresh culture medium, cells were plated into 
the wells of a 384-well plate. Within the following 
24 – 32 h, the cell culture medium was replaced by 
an extracellular control solution (140 mM NaCl, 5 
mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM 
HEPES, and 10 mM glucose, pH 7.4). Cells were 
imaged using YFP-I152L fluorescence quench as 
an indicator of the anion influx rate (19). 
Fluorescence images of each well were obtained 
twice: once before and once after the application of 
a sodium iodide solution (140 mM NaI, 5 mM KCl, 
2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 
10 mM glucose, pH 7.4) containing defined 
concentrations of glycine. Mean percentage quench 
values represent data averaged from three 
experiments carried out on different plates. Each 
experimental value was an average of the 
percentage quench of all fluorescent cells in three 
wells on the same plate, with each well containing 
> 200 cells.  
Electrophysiology - Glycine-gated currents were 
measured in HEK AD293 cells transfected as 
described above by whole-cell patch-clamp 
electrophysiology at -40 mV. Alternatively, single-
channel currents were recorded from outside-out 
excised patches. During experiments, cells were 
continually superfused with the extracellular 
control solution as detailed above. Patch pipettes 
were pulled to a tip resistance of 1 – 4 MΩ (whole-
cell) or 6 – 12 MΩ (outside-out) when filled with a 
standard internal solution (145 mM CsCl, 2 mM 
CaCl2, 2 mM MgCl2, 10 mM HEPES, 10 mM 
EGTA, pH 7.4). Using an Axon MultiClamp 700B 
amplifier (Molecular Devices), whole-cell currents 
were filtered at 1 kHz and digitized at 2 kHz 
whereas single-channel currents were filtered at 2 
kHz and digitized at 5 kHz. Voltage-clamp 
fluorometry experiments were performed as 
previously described (20). Briefly, oocytes were 
removed from the ovaries of Xenopus laevis frogs, 
incubated in OR-2 (82.5 mM NaCl, 2 mM KCl, 1 
mM MgCl2, 5 mM HEPES, pH 7.4) containing 1.5 
mg/ml collagenase for 2 h at room temperature on a 
shaker and injected with 10 ng of RNA generated 
form wild type or mutated human α1 GlyR. All 
constructs contained the functionally silent C41A 
mutation	  (21). Oocytes were cultured for 2 – 3 days 
at 18 °C in ND96 (96 mM NaCl, 2 mM KCl, 1 mM 
MgCl2, 1.8 mM CaCl2, 5 mM HEPES, pH 7.4) 
containing 275 mg/l sodium pyruvate, 110 mg/l 
theophylline and 0.1 % (v/v) gentamicin. For 
labelling, oocytes were incubated with 10 µM 
sulforhodamine methanethiosulfonate (MTSR) 
diluted in ND96 for 1 min on ice. 3 mM KCl was 
used as internal solution and recordings were 
performed at -40 mV.  
Statistical analysis - EC50, nH and Imax or Fmax 
values for glycine-induced activation of current and 
fluorescence were obtained using the Hill equation 
fitted with a non-linear least squares algorithm 
(SigmaPlot 12.0). All results are expressed as mean 
± S.E.M. of three or more independent experiments 
and statistical analysis was performed using one 
way ANOVA followed by post-hoc test or 
Student’s paired t-test, as appropriate, with 
significance at P < 0.05. 
Western blotting – HEK AD293 cells transfected as 
described above were lyzed two days after 
transfection with a sample buffer containing 2 % 
Sodium Dodecyl Sulfate (w/v), 10 % glycerol (v/v) 
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and 0.1 M Tris, pH 6.8. To break potential 
disulfide bonds, whole-cell lysates were treated 
with 100 mM dithiothreitol (DTT). After sodium 
dodecyl sulfate (SDS) polyacrylamide gel 
electrophoresis (PAGE) and Western blotting, 
proteins were detected with rabbit anti-GlyR α1 
primary antibody (Millipore, 1:3000) and 
subsequently with a goat anti-rabbit horseradish 
peroxidase-conjugated secondary antibody (Santa 
Cruz Biotechnology, 1:50000). All experiments 
were replicated at least three times.  
 
RESULTS 
 
Identification of residues interacting with Q226 
and V280 - The crystal structure of the C. elegans 
α glutamate-gated chloride channel receptor 
(GluClR) has recently been determined in the open 
state (22). As it shares a 34% amino acid sequence 
identity with the α1 GlyR, it provides the highest 
homology structural template available for 
identifying candidate residues that may interact 
with Q226 and V280. The α GluClR residues Q219 
and N264 (which correspond to Q226 and R271 in 
the α1 GlyR) are closely apposed across the 
subunit interface, where their α carbon (Cα) atoms 
are separated by a distance of 8.3 Å (Fig. 1A). 
Residues corresponding to both Q226 and R271 are 
highly conserved in GABAARs and GlyRs (Fig. 
1C) and their close apposition suggests that an 
energetic interaction, possibly an H-bond, may 
exist between them in the open state. The GluClR 
structure reveals that residues L218 and I273 
(which correspond to I225 and V280 in the α1 
GlyR) are also apposed across the subunit 
interface, with Cα−Cα separation of 8.9 Å (Fig. 
1B). These residues are also highly conserved in 
anionic pLGICs (Fig. 1C), with their chemical 
properties suggesting the existence of a 
hydrophobic interaction between them. 
    To determine whether the relative orientations of 
these residue pairs are altered as the channel opens, 
we compared the distances between their respective 
Cα atoms in ELIC and GLIC, which are bacterial 
pLGICs crystallized in closed and open state 
conformations, respectively	   (23-25). The locations 
of the ELIC and GLIC residues corresponding to 
I225, Q226, R271 and V280 in the α1 GlyR are 
shown in Fig. 1D. In ELIC, the Cα−Cα separation 
of residues corresponding to Q226 and R271 is 
10.0 Å. In GLIC, this distance is reduced to 7.5 Å, 
similar to GluClR (8.3 Å), suggesting that Q226 
and R271 move closer together as the channel 
opens. On the other hand, the Cα−Cα separation of 
residues corresponding to I225 and V280 is 7.6 Å 
in ELIC, 9.0 Å in GLIC and 8.9 Å in GluClR, 
suggesting their respective domains move apart 
when the channel opens. As agonist binding signals 
are transmitted to the gate via movements applied 
to the external end of the TM α-helices	   (8,9), we 
propose that the TMD reorientations as depicted in 
Fig. 1D may be responsible for initiating channel 
opening. This in turn prompts us to hypothesize 
that the Q226E mutation induces spontaneous 
activity via an increased electrostatic attraction to 
R271 thus stabilizing the domains in a closely 
apposed conformation which would mimic the 
open state. We further hypothesize that the 
increased side chain volume of the V280M 
hyperekplexia mutation produces spontaneous 
activity by sterically repelling I225 and thus also 
mimicking the open state conformational change. 
 
Evidence for a direct interaction between Q226 
and R271 - To test whether Q226 and R271 
physically interact, the following three mutations 
were made: Q226R, R271Q and Q226R/R271Q. 
The R271Q mutation, which occurs naturally in 
human hyperekplexia, is known to drastically 
reduce both glycine sensitivity and single channel 
conductance (26-29). If the Q226R mutation 
rescues the effects of R271Q by restoring side 
chain complementarity, we would propose a 
physical interaction exists between the two 
residues. To assess the functional properties of 
these mutants, HEK AD293 cells were transfected 
with each construct in turn and glycine dose-
response relationships were quantitated by whole-
cell patch-clamp electrophysiology. Fig. 2A shows 
sample dose-response recordings for the wild type 
and the three mutated constructs and in Fig. 2B the 
normalized mean current amplitudes are plotted 
against the applied glycine concentration for each 
construct. The mean glycine EC50 values are 
presented in Fig. 2C and all averaged curve fit 
parameters are summarized in Table 1. The glycine 
EC50 values for receptors incorporating Q226R or 
Q226R/R271Q were near 1.5 mM whereas the 
EC50 value for R271Q GlyRs was near 12 mM, as 
previously shown (27). These results indicate that 
Q226R partially compensates for the reduced 
glycine sensitivity of R271Q. Further, GlyRs 
incorporating R271Q exhibited dramatically 
reduced maximal current amplitudes that were also 
compensated by the Q226R mutation (Fig. 2D, 
Table 1). As the R271Q mutation reduces the 
dominant single channel conductance state from 
around 90 to 15 pS (26,28), single channel 
recordings of Q226R and Q226R/R271Q receptors 
were performed to evaluate whether the Q226R 
mutation can also compensate for the reduced 
conductance. Single channel current-voltage 
relationships for receptors containing Q226R or 
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Q226R/R271Q mutations revealed unitary 
conductances similar to those of α1 wild type 
GlyRs (Fig. 2E, F). As there was no significant 
difference in the single channel conductance of 
receptors containing the wild type, Q226R or 
Q226R/R271Q subunits, we conclude that an 
arginine at Q226 can compensate for the drastically 
reduced conductance of the R271Q receptor. This 
compensation of both the glycine sensitivity and 
the single channel conductance strongly suggests 
that these two residues lie in close proximity. To 
calculate the coupling energy between them, 
mutant cycle analysis was performed as described 
previously	  (30,31)	  using the equation:  
 ΔG = −𝑅𝑇𝑙𝑛 𝐸𝐶!",!! ∗ 𝐸𝐶!",!!𝐸𝐶!",!" ∗ 𝐸𝐶!",!"  
 
where ΔG is the coupling energy, R is the universal 
gas constant, T is temperature (K), EC50,ww is the 
wild type EC50 value,  EC50,mm is the double mutant 
EC50 value, and  EC50,mw and EC50,wm are the two 
single mutant EC50 values. This equation predicts 
the coupling energy between Q226 and R271 to be 
13.2 kJmol-1. If the N264 residue in the GluClR 
structure was substituted by an arginine, the 
distance between the polar oxygen group of Q219 
and the positively charged nitrogen group of R264 
would be 7 Å. In comparison with interactions as 
assayed in other proteins	  (32), a coupling energy of 
13.2 kJmol-1 for residues lying 7 Å apart is high 
indicating a strong attractive interaction between 
Q226 and R271.  
   We next generated the Q226C, R271C and 
Q226C/R271C mutant GlyRs to determine whether 
Q226 and R271 lie sufficiently close together for 
disulfide trap to occur. Two cysteine residues can 
form a disulfide bridge if their Cα-Cα separation 
distance is not more than 6.5 Å	  (33). Although the 
Cα-Cα separation of 8.3 Å (based on the GluClR 
structure) is too large for crosslinking to occur, 
random thermal motions or glycine-mediated 
gating motions may be of sufficient magnitude for 
disulfide trap to occur. Of course, the mean 
Cα−Cα separation in α1 GlyRs may also be 
reduced. The first step was to quantitate the glycine 
EC50 values of the Q226C, R271C and 
Q226C/R271C receptors. As shown in Fig. 3A, B, 
and summarized in Table 1, the glycine EC50 
values of all three mutated receptors were increased 
relative to the wild type receptor. Interestingly, the 
glycine sensitivity for Q226C/R271C receptors was 
less reduced than for receptors containing the 
single mutations Q226C or R271C. Using the 
above equation, the coupling energy between the 
respective residues was calculated to be 15.3 
kJmol-1 confirming the strong energetic interaction 
as reported above.  
    To probe for disulfide bond formation, we 
investigated the effects of an oxidizing and a 
reducing agent on the double mutant 
Q226C/R271C receptor. First, an EC50 (1.5 mM) 
glycine concentration was applied several times to 
establish a stable baseline. Cells were then perfused 
with 2 mM DTT for 1 min followed by two glycine 
EC50 applications separated by 30 s. Following 
that, 0.3 % H2O2 was applied for 1 min also 
followed by two glycine EC50 applications. A 
sample experiment is shown in Fig. 3C (upper 
trace). Although the initial DTT application 
significantly increased current to 116 ± 5 % of 
control (n = 6 cells; P < 0.05 by paired t-test), 
neither a subsequent H2O2 application (111 ± 8 %) 
nor a second DTT application (114 ± 9 %) exerted 
a significant effect on current magnitude. As we 
propose that Q226 and R271 are closer in the open 
state, the effect of oxidizing and reducing agents on 
the current amplitude was also tested in the 
presence of EC50 glycine. Therefore the oxidizing 
agent H2O2 was applied together with an EC50 
glycine to simulate the open state in which 
crosslinking might occur. However, as shown in 
Fig. 3C (lower trace), no significant effect relative 
to the initial control current was observed after the 
application of DTT (91 ± 6 %, n = 5 cells) and 
H2O2 containing EC50 glycine (93 ± 5 %) as well as 
after a second application of DTT (101 ± 13 %). 
From this we conclude that either no crosslinks 
were formed or that the applied agents could not 
access a pre-formed disulfide bond. We thus 
employed Western blotting to probe directly for 
dimer formation. Surprisingly, both the Q226C and 
R271C single mutant GlyRs formed subunit dimers 
that were reduced by DTT (Fig. 3D). The double 
mutant Q226C/R271C GlyR formed not only 
dimers but also tetrameric or pentameric aggregates 
that were relatively resistant to reduction by DTT. 
As discussed in detail below, these data do not 
provide unequivocal evidence for dimer formation 
in assembled Q226C/R271C GlyRs. 
	  
Evidence for a direct interaction between V280 and 
I225 - The V280M mutant GlyR also exhibits a 
high level of spontaneous channel activity	  (18). As 
valine and methionine are both hydrophobic but 
methionine is larger, we hypothesized that the 
spontaneous activity arises from a steric repulsion 
between V280 and I225 of the adjacent subunit 
(Fig. 1). To test whether the level of spontaneous 
activity is dependent on the volume of the side 
chain, we mutated V280 in turn to the hydrophobic 
amino acids, alanine, leucine and tryptophan. The 
side chain volume in water per residue is 78.9 Å3 
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for valine, 103.2 Å3 for methionine, 28.9 Å3 for 
alanine, 107.0 Å3 for leucine and 167.3 Å3 for 
tryptophan. HEK AD293 cells were transfected 
with each mutant construct in turn and a yellow 
fluorescent protein anion influx assay (19) was 
employed to quantify the relative magnitudes of 
spontaneous anion influx in each mutated receptor. 
The fluorescence assay was necessary as the high 
level of spontaneous activity in V280L and V280W 
mutant GlyRs meant that it was difficult to achieve 
stable electrophysiological recordings. In these 
experiments, cells were bathed initially in NaCl 
solution and the percentage reduction in quench 
was quantitated upon replacement of the control 
NaCl solution with NaI solution plus or minus 
glycine. Because YFP-I152L is quenched by iodide 
but not by chloride ions (19), potent quench by 
iodide in the absence of glycine indicates 
spontaneously active channels. In Fig. 4A, the 
fluorescence quench was plotted against the 
applied glycine concentration. For wild type 
receptors, the glycine EC50 and the maximal 
fluorescence quench values (expressed as a 
percentage of control fluorescence) were 16.9 ± 3.0 
µM and 48 ± 1 %, respectively, whereas the 
corresponding values for V280A receptors were 5.6 
± 1.7 µM and 40 ± 1 %, respectively. The V280A 
GlyR showed no evidence of spontaneous activity, 
and the glycine sensitivity of these receptors was 
similar to that previously demonstrated using 
electrophysiology	   (34). We thus infer that a small 
hydrophobic substitution at position 280 does not 
induce spontaneous activity. In contrast, receptors 
incorporating V280M, V280L or V280W 
mutations exhibited a strong quench upon addition 
of glycine-free NaI solution with a magnitude that 
was proportional to side chain volume (Fig. 4B). 
We hence conclude that the level of spontaneous 
activity is proportional to side chain volume at 
position 280.  
    To test whether I225 and V280 interact, we 
generated the single mutant I225C and V280C 
receptors and the double-mutant I225C/V280C 
receptor. Using whole-cell patch-clamp 
electrophysiology, we found that the glycine 
sensitivity of receptors incorporating I225C or 
V280C mutations was modestly increased (Fig. 
5A-C, Table 1). In contrast, the glycine sensitivity 
of I225C/V280C receptors was significantly 
reduced resulting in a coupling energy of -7.7 
kJmol-1 between the two side chains. As the 
Cα−Cα separation of residues corresponding to 
I225 and V280 is 9 Å in the GluClR structure, this 
energy value can be considered as very high 
relative to the coupling energy for other residue 
pairs	  (32).  
    To determine whether any of the cysteine mutant 
GlyRs exhibited spontaneous channel activity, we 
quantitated the relative magnitudes of the current 
inhibited by 100 µM picrotoxin as a percentage of 
the current activated by saturating (10 mM) glycine 
in the same cell. A sample experiment for the 
V280C mutant GlyR, revealing a large spontaneous 
current, is shown in Fig. 5D. The results averaged 
for the I225C, V280C and I225C/V280C mutant 
GlyRs are summarized in Fig. 5E. We propose the 
large leak current in the V280C mutant GlyR can 
be explained by the disruption of a hydrophobic 
bond that helps to maintain the close separation 
between these residues in the closed state.  
    We next investigated the possibility of disulfide 
bond formation between I225C and V280C. We 
applied DTT and H2O2 as previously described 
while monitoring the magnitude of 100 µM 
glycine-gated currents. The mean current 
magnitude changes expressed as percentages of the 
original control current magnitude were as follows: 
after first DTT application: 106 ± 16 %, after 
subsequent H2O2 application: 94 ± 27 %, after 
second DTT application: 97 ± 31 %. All results 
were averaged from the same six cells and revealed 
no significant differences in current magnitude (P > 
0.05 by paired t-test). A Western blot also showed 
no evidence for dimer formation. We thus infer that 
I225C and V280C interact energetically but do not 
form a disulfide bond (data not shown).  
 
Effects of Q226E and V280M on TM2-TM3 loop 
conformation - Glycine-induced conformational 
changes are transmitted from the glycine-binding 
site to the gate via conformational changes in the 
TM2-TM3 domain (8,9,34). To determine the 
effect of Q226E and V280M mutations on TM2-
TM3 conformation and vice versa, we next 
employed K276C receptors. K276 is located in the 
TM2-TM3 loop and it has previously been shown 
that cysteines introduced at the position 
corresponding to K276 in GABAAR β2 subunits 
are able to efficiently crosslink neighbouring β2 
subunits in α1β2 GABAARs	   (35). Our first 
approach involved determining whether K276C 
residues could also crosslink in α1 GlyRs, and if 
so, whether these crosslinks could be disrupted by 
the Q226E or V280M mutations. We thus 
generated the K276C single mutant GlyR and the 
Q226E/K276C and K276C/V280M double mutant 
GlyRs. These constructs were transfected into HEK 
AD293 cells and whole-cell glycine dose-response 
relationships were determined. For receptors 
containing K276C, the glycine sensitivity was 
dramatically reduced (Fig. 6A, Table 1) as 
previously described	  (21). In contrast, for receptors 
containing Q226E/K276C or K276C/V280M, the 
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sensitivity to glycine was only modestly reduced to 
500 µM and 90 µM, respectively. Glycine dose-
response recordings were also performed after the 
application of 2 mM DTT for 1 min, however, no 
significant changes in the glycine sensitivity were 
detected (Fig. 6A, Table 1). Interestingly, the 
current amplitude for K276C receptors was 
significantly increased after the application of DTT 
(Table 1). We also probed the three receptors for 
spontaneous channel activity using the method as 
described above (Fig. 5D, E). No inhibitory effect 
of picrotoxin was observed in Q226E/K276C 
GlyRs (n = 4 cells). In contrast picrotoxin inhibited 
2.5 ± 0.6% (n = 4 cells) of the saturating glycine-
activatable current in K276C/V280M GlyRs. 
    To probe for disulfide bond formation, 2 mM 
DTT and 0.3 % H2O2 were applied alternately for 1 
min each, as described above, while the magnitude 
of currents activated by EC50 glycine (3000 µM for 
K276C, 500 µM for Q226E/K276C and 90 µM for 
K276C/V280M) was monitored. In K276C mutant 
GlyRs, DTT significantly increased current 
magnitude whereas H2O2 rapidly and irreversibly 
reduced current magnitude (Fig. 6B, C), consistent 
with the formation and breakage of crosslinks 
between adjacent subunits. However, the 
Q226E/K276C and K276C/V280M receptors 
showed no significant response to either DTT or 
H2O2 treatment, suggesting either that crosslink 
formation did not occur or that crosslinks had pre-
formed spontaneously and could not be reduced by 
DTT.   
    To resolve between these possibilities, we 
performed a Western blot analysis on the wild type 
and all three mutated constructs (Fig. 6D). 
Compared to α1 wild type receptors that did not 
form dimers, all mutant receptors exhibited a 
similar incidence of dimer formation that was 
reversed by DTT. Our results are consistent with a 
model whereby the reduction of crosslinks in 
K276C GlyRs enhances TM2-TM3 loop flexibility 
and leads to more efficacious glycine-induced 
activation. In contrast, crosslink reduction does not 
enhance glycine-induced current magnitudes in 
either of the double mutant GlyRs. We infer that 
the Q226E and V280M mutations position the TM 
α-helices into a conformation that is already highly 
conductive to efficacious glycine-induced 
activation. In such a scenario, breakage of the 
disulfide bonds would exert no additional 
enhancement of glycine efficacy and thus exert no 
effect on glycine-gated current magnitudes.  
    The effects of Q226E and V280M mutations on 
conformational changes near R271 were 
quantitated using voltage-clamp fluorometry (36). 
In this technique, a sulfhydryl-tagged fluorophore 
(often a rhodamine derivative) is covalently 
attached to a cysteine introduced into a receptor 
domain of interest. Because rhodamine 
fluorescence exhibits an increase in quantum 
efficiency as the hydrophobicity of its environment 
is increased, glycine-induced changes in 
fluorescence intensity can be interpreted as local 
conformational changes. These experiments were 
carried out in Xenopus oocytes as the detection of 
small glycine-induced fluorescence changes is not 
routinely possible in HEK AD293 cell-expressed 
receptors. 
    Previously, we reported that MTSR 
(sulforhodamine methanethiosulfonate), when 
covalently attached to R271C in TM2 of the 
homomeric α1 GlyR, exhibited an increase in 
fluorescence intensity upon glycine binding (20). 
As the glycine concentration-response relationships 
for current and fluorescence were overlapping, we 
concluded that conformational changes at the 
channel gate (as reported by the current response) 
were tightly coupled with conformational changes 
near R271 (as reported by the fluorescence 
response). As we sought to investigate the effect of 
the Q226E and V280M mutations on these glycine-
induced fluorescence changes, we compared 
current and fluorescence responses in the R271C 
single mutant GlyR and the Q226E/R271C and 
R271C/V280M double mutant GlyRs. Averaged 
glycine current dose-response relationships for 
unlabeled and MTSR-labeled R271C mutant GlyRs 
are shown in Fig. 7A, with mean glycine EC50, nH 
and Imax/Fmax values summarized in Table 2. As 
previously demonstrated, the glycine fluorescence 
dose-response in the MTSR-labeled GlyR 
overlapped with the current dose-response. 
    This experimental approach was repeated on 
Q226E/R271C and R271C/V280M mutant GlyRs. 
The glycine EC50 for unlabeled Q226E/R271C 
GlyRs was near 1700 µM (Fig. 7B, Table 2). In 
MTSR-labeled Q226E/R271C GlyRs the current 
EC50 was near 600 µM and the fluorescence EC50 
was significantly higher at around 1000 µM. For 
R271C/V280M receptors, the glycine EC50 was 
dramatically reduced due to the presence of 
V280M. The glycine EC50 for unlabeled receptors 
was 12 µM and for MTSR-labeled receptors the 
current EC50 was 2 µM and the fluorescence EC50 
was significantly higher at 6 µM (Fig. 6C, Table 2). 
These results indicate that the hyperekplexia 
mutations uncouple conformational changes at the 
channel gate from conformational changes 
occurring near to R271.  
    Finally, the effect of the pore blocker picrotoxin 
was tested on all three receptors to confirm whether 
spontaneous activity was present in the double 
mutant GlyRs. For R271C/V280M GlyRs, the 
application of 100 µM picrotoxin blocked a leak 
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current which corresponded to 68 ± 21 % of the 
saturating (30 mM) glycine-activatable current. 
However, no significant change in baseline current 
was detected for receptors containing R271C or 
Q226E/R271C GlyRs (n = 4 for each receptor). For 
all three receptors, no change in fluorescence was 
detected upon the application of picrotoxin 
suggesting that the environment of residue R271 
does not change when picrotoxin blocks the pore.  
 
DISCUSSION 
 
The interaction between Q226 and R271 - As the 
Cα−Cα separation of Q226 and R271 is predicted 
to reduce from 10 to ~8 Å as the channel opens 
(Fig. 1), we hypothesized that the spontaneous 
activity induced by Q226E was due to an enhanced 
electrostatic attraction to R271. To test this, we 
introduced a positive charge at Q226 via the 
Q226R mutation. Separately, we also eliminated 
the positive charge at R271 via the R271Q 
mutation. Both mutations dramatically reduced 
glycine sensitivity, consistent with our hypothesis. 
However, the double Q226R/R271Q mutant GlyR 
largely restored glycine sensitivity, with mutant 
cycle analysis demonstrating a strong energetic 
attraction between the two residues. This result 
provides strong support for our hypothesis.  
    The positive charge at R271 enhances the GlyR 
single channel conductance via a direct 
electrostatic interaction with the permeating anions 
(37), thus explaining why the R271Q human 
hyperekplexia mutation drastically reduces single 
channel conductance (26,28). This reduction in 
conductance was entirely reversed by inserting the 
positive charge at Q226 in the Q226R/R271Q 
double mutant GlyR (Fig. 2E-F). Although this 
does not provide evidence for an energetic 
interaction between Q226 and R271, it does 
suggest that the two residues are located in 
sufficiently close proximity that the removal of a 
positive charge from one site can be compensated 
by the addition of a positive charge to the other. 
    Our attempt to demonstrate proximity between 
Q226 and R271 via cysteine trapping yielded 
equivocal results. Although we demonstrated a 
strong energetic coupling between Q226C and 
R271C via mutant cycle analysis, we found that 
oxidizing and reducing agents had no significant 
effect on glycine-activated current magnitudes. 
Western blotting showed that Q226C/R271C 
double mutant GlyRs could indeed form dimer 
complexes, as predicted. However, because single 
mutant Q226C or R271C GlyRs could also form 
dimers, and Q226C/R271C GlyRs could form 
pentameric or tetrameric subunit aggregates, we 
could not rule out the possibility of other 
mechanisms contributing to subunit aggregation. 
    We conclude that GlyRs can be activated 
directly by increasing an electrostatic attraction 
between Q226 at the top of TM1 and R271 at the 
top of TM2 of the neighbouring subunit. In wild 
type GlyRs, the formation of an H-bond between 
Q226 and R271 may help stabilize the glycine-
induced open state. When taken together with the 
crystal structure information (Fig. 1), we propose 
this enhanced attraction would tilt the outer end of 
TM2 away from the pore axis, resulting in pore 
opening.  
 
The interaction between V280 and I225 - 
Comparison of closed and open state pLGIC 
structures suggests that the Cα−Cα separation of 
V280 and I225 increases from 7.6 to ~9 Å as the 
channel opens (Fig. 1). We therefore hypothesized 
that the spontaneous activity in the V280M mutant 
GlyR was due to the larger methionine side chain 
exerting a steric repulsion from I225. This would 
increase the separation of TM1 and TM3, and thus 
mimic the closed to open state structural change. 
To test this hypothesis, we introduced 
progressively larger hydrophobic side chains at 
V280 and monitored both glycine sensitivity and 
the mean level of spontaneous channel activity. We 
found that larger side chains did indeed induce 
higher levels of spontaneous activity, consistent 
with our hypothesis. Although our attempts to 
demonstrate proximity between V280 and I225 via 
cysteine trapping were unsuccessful, we did 
demonstrate a significant energetic coupling 
between V280C and I225C via mutant cycle 
analysis. In this case the individual cysteine 
mutations had little effect on the glycine EC50 
value, but the double cysteine mutant receptor 
exhibited dramatically reduced glycine sensitivity. 
This suggests that the double cysteine substitution 
(I225C/V280C) may have increased the space 
available for the respective domain backbones to 
move closer together, stabilizing the closed state. 
   The V280C mutant GlyR exhibited a leak current 
that was larger than may be expected due to its 
sidechain volume (Fig. 5D). This can be explained 
by the disruption of a putative hydrophobic bond 
that helps to maintain the close apposition between 
V280 and I225 in the closed state. 
    A comparison of GLIC versus ELIC structures 
reveals that during channel opening, the top of the 
TM1 does not move although the top of TM3 
moves radially outwards from the pore in parallel 
with TM2	   (7,23,25). When taken in conjunction 
with our functional evidence, we propose that 
increasing the side chain volume at V280 tilts the 
top of TM3 radially outwards against the stationary 
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TM1 of the adjacent subunit, thus providing space 
for TM2 to relax away from the pore axis to create 
an open channel. Consistent with this mechanism, 
ivermectin is also thought to open the GluClR by 
directly spreading TM1 and TM3	  (22). 
 
Effects of mutations on subunits dimerized via 
K276C crosslinks - Two findings prompted us to 
conclude that GlyR α1 subunits dimerize via 
disulfide bonds between their respective K276C 
residues. First, current magnitude in K276C mutant 
GlyRs was dramatically increased by a reducing 
agent and irreversibly reduced by an oxidizing 
agent. Second, dimer formation was directly 
demonstrated by Western blotting. These results 
are consistent with a previous study on α1β2 
GABAARs where β2 subunits were shown to 
dimerize via crosslinks between TM2-TM3 loop 
residues corresponding to K276C (35). Cα−Cα 
separation must usually be < 6 Å for disulfide bond 
formation to occur	  (33). In the ELIC, GLIC and α 
GluClR crystal structures, the Cα−Cα separation of 
residues corresponding to K276 in adjacent 
subunits is 20 - 24 Å (22-25). Given this large 
distance, dimerization via K276C crosslinks 
provides evidence for exceptionally large thermal 
motions in the TM2-TM3 loop of α1 subunits. We 
cannot rule out the possibility of dimer formation 
between non-adjacent subunits, but this would 
implicate an even greater Cα−Cα separation. 
    Our results are consistent with a model whereby 
the reduction of crosslinks in K276C GlyRs 
enhances TM2-TM3 loop flexibility and thereby 
leads to more efficacious glycine-induced 
activation. Given that a maximum of two dimer 
pairs can exist per receptor, it is clear that at least 
one (and possibly both) crosslinks must be reduced 
for maximally efficacious receptor activation.  
However, the reduction of K276C crosslinks did 
not enhance glycine-induced current magnitudes in 
Q226E/K276C or K276C/V280M double mutant 
GlyRs. We therefore infer that Q226E or V280M 
mutations configure the GlyR TMD into a 
conformation conducive to maximally efficacious 
glycine-induced activation. In such a scenario, the 
increased flexibility in the TM2-TM3 loop induced 
by reduction of the disulfide bonds would exert no 
additional effect on glycine-gated current 
magnitudes. 
 
Conclusion - We have described how the 
hyperekplexia mutations, Q226E and V280M, 
induce spontaneous GlyR activation. The 
mechanism we propose is consistent with the 
structural differences evident in the X-ray atomic 
structures of closed and open state pLGICs 
suggesting that it may be broadly applicable across 
the eukaryotic pLGIC receptor family. In addition, 
a specific prediction of our study is that an H-bond 
between Q226 in TM1 and R271 in TM2 in the 
neighbouring subunit is necessary for stabilizing 
the GlyR in the open state. 
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FIGURE LEGENDS 
 
Fig. 1. Location of residues hypothesized to interact with the α1 GlyR residues, Q226 and V280. A. Model 
of the C. elegans α GluClR (PDB 3RIF) showing two neighbouring subunits (coloured light and dark grey, 
respectively), with residues homologous to α1 GlyR Q226 and R271 coloured light and dark purple, 
respectively. The lower panel shows the view towards the membrane from the extracellular space with the 
ECD removed. B. Same structure and orientations as in A, but with residues homologous to α1 GlyR I225 
and V280 coloured light and dark blue, respectively. C. Multiple sequence alignment of the TMD regions 
indicated pLGIC receptors with Q226 and V280 and their interacting residues coloured as in panels A and B. 
D. Model structures of ELIC (left, PDB 2VLO) and GLIC (right, PDB 3EAM) showing two neighbouring 
subunits (coloured light and dark grey, respectively) viewed towards the membrane from the extracellular 
space with the ECD removed. As in panels A and B, residues homologous to α1 GlyR Q226, R271, I225 and 
V280 are coloured light and dark purple and light and dark blue, respectively. 
 
Fig. 2. Electrophysiological characterization of Q226R, R271Q and Q226R/R271Q mutant α1 GlyRs. A. 
Examples of currents activated by indicated glycine concentrations for each receptor type. In this and 
subsequent figures, thin horizontal bars indicate the duration of glycine applications and numbers represent 
glycine concentration in µM. B. Averaged normalized glycine dose-response relationships for the four 
receptors. C. Mean glycine EC50 values. *** P < 0.001 relative to α1 GlyR via one way ANOVA followed 
by Dunnett’s post-hoc test. D. Mean maximal glycine-mediated current amplitudes. ** P < 0.01 relative to 
α1 GlyR via one way ANOVA followed by Dunnett’s post-hoc test. E. Averaged single channel current-
voltage relationships for the indicated receptors recorded in outside-out patches. The wild type, Q226R and 
Q226R/R271Q GlyRs exhibited mean single channel conductance values of 92 ± 4 pS (n = 3), 99 ± 4 pS (n = 
6) and 98 ± 3 pS (n = 6), respectively. These values were not significantly different to each other using one 
way ANOVA followed by Tukey’s post-hoc test. The R271Q current-voltage relationship, shown previously 
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to be 15 pS	  (26,28), is indicated as a dashed line. F. Sample single channel activations in wild type, Q226R 
and Q226R/R271Q GlyRs recorded at -80 mV. Channel openings are downward, with dashed lines denoting 
the main open conductance level. Channel amplitude histograms are also displayed. In this analysis we only 
included sections of recording in which the channel exhibited a stable transition from one conductance level 
to another. We did not include sections of record containing unresolved channel openings. As the histograms 
reveal an absence of stable openings at subconductance levels, we infer that the brief openings of reduced 
magnitude were mostly unresolved larger amplitude events curtailed by filtering. 
 
Fig. 3. Electrophysiological and biochemical characterisation of Q226C, R271C and Q226C/R271C mutant 
α1 GlyRs. A. Averaged normalized glycine dose-response relationships for the four receptors. B. Mean 
glycine EC50 values. ** P < 0.01, *** P < 0.001 relative to α1 GlyR via one way ANOVA followed by 
Dunnett’s post-hoc test. C. Examples of current traces activated by EC50 glycine (1.5 mM) in Q226C/R271C 
GlyRs,.The first two traces in each row were recorded from a naïve cell. Subsequent traces were recorded 
following 1 min applications of 2 mM DTT or 0.3% H2O2 (together with EC50 glycine for the lower trace) as 
indicated. Averaged results are presented in the text. D. Western blot of wild type, Q226C, R271C and 
Q226C/R271C mutant α1 GlyRs in the absence and presence of 100 mM DTT as indicated. A protein 
preparation from untransfected cells is included as a control. Numbers on the left represent size in kD. 
Similar results were obtained in blots performed on three separate protein preparations. 
 
Fig. 4. Functional characterisation of α1 GlyRs incorporating mutations at V280. A. Glycine-dependence of 
fluorescent quench for the wild type, V280M, V280A, V280L and V280W mutant GlyRs using the YFP-
I152L anion influx assay. The percentage quench is equal to (1 - final fluorescence/control fluorescence) X 
100%. All displayed data points represent the average quench from three experiments with three wells each 
and > 200 cells per well. B. Mean percentage quench in the absence of glycine for the indicated receptors. 
*** P < 0.001, **** P < 0.0001 relative to α1 GlyR via one way ANOVA followed by Dunnett’s post-hoc 
test.  
 
Fig. 5. Electrophysiological characterisation of I225C, V280C and I225C/V280C mutant α1 GlyRs. A. 
Examples of currents activated by indicated glycine concentrations for each receptor type. B. Averaged 
normalized glycine dose-response relationships for wild type and indicated mutant receptors. C. Mean 
glycine EC50 values. **** P < 0.0001 relative to α1 GlyR via one way ANOVA followed by Dunnett’s post-
hoc test. D. Sample trace for V280C mutant α1 GlyRs showing the maximal glycine-induced current 
amplitude and the inhibition of the leak current by 100 µM picrotoxin. E. Magnitude of picrotoxin-inhibited 
current expressed as a percentage to the maximal glycine-gated current amplitude. * P < 0.05, *** P < 0.001 
relative to α1 GlyR via one way ANOVA followed by Dunnett’s post-hoc test.  
 
Fig. 6. Effects of Q226E and V280M on GlyR dimerization via K276C crosslinks. A. Averaged normalized 
glycine dose-response relationships for wild type and indicated mutant receptors before and after the 
application of 2 mM DTT. B. Sample current recordings of K276C, Q226E/K276C and K276C/V280M 
GlyRs activated by EC50 glycine (3000 µM, 500 µM and 90 µM, respectively). The first two traces were 
recorded from a naïve cell. Subsequent traces were recorded following 1 min applications of 2 mM DTT or 
0.3% H2O2 as indicated. C. Normalized glycine EC50 current amplitudes of K276C, Q226E/K276C and 
K276C/V280M GlyRs before and after the application of DTT and H2O2. The normalized currents are 
represented in percentages. p-values were calculated relative to the control current with a paired t-test: * P < 
0.05. B. Western blot of wild type, Q226C, R271C and Q226C/R271C mutant α1 GlyRs in the absence and 
presence of 100 mM DTT as indicated. A protein preparation from untransfected cells is included as a 
control. Numbers on the left represent size in kD. Similar results were obtained in blots performed on three 
separate protein preparations. 
 
Fig. 7. Effects of Q226E and V280M on conformational changes near TM2 as determined by voltage-clamp 
fluorometry. A-C. Averaged normalized glycine dose-response relationships for both current (black 
triangles) and fluorescence (red triangles) at MTSR-labeled R271C, Q226E/R271C and R271C/V280M 
GlyRs using voltage-clamp fluorometry. Current dose-response relationships for unlabeled receptors are also 
shown (black circles). Mean parameters of best fit to individual dose-response relations are presented in 
Table 2. D. Examples of simultaneous current (black) and fluorescence (red) recordings from oocytes 
expressing labeled R271C GlyRs (upper traces) and R271C/V280M GlyRs (lower traces). 
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Table 1. Properties of wild type and indicated mutant α1  GlyRs using whole-cell patch-clamp 
electrophysiology 
  
 
Whole-cell patch-clamp electrophysiology 
EC50  
(µM) nH 
Imax  
(nA) n 
α1 % 64 ± 8 3.8 ± 0.3 19 ± 3 10 
α1-Q226R 1705 ± 334 1.3 ± 0.2**** 15 ± 5 6 
α1-R271Q 12100 ± 
4592*** 1.2 ± 0.1**** 2 ± 1** 6 
α1-Q226R/R271Q 1547 ± 145 2.1 ± 0.2*** 13 ± 2 6 
α1-Q226C 5944 ± 2065** 1.1 ± 0.1**** 16 ± 3 7 
α1-R271C 8635 ± 2329*** 1.0 ± 0.1**** 3 ± 1** 6 
α1-Q226C/R271C 1657 ± 206 0.9 ± 0.0**** 5 ± 1** 6 
α1-I225C 54 ± 13 1.1 ± 0.1*** 27 ± 5 3 
α1-V280C 26 ± 8 1.6 ± 0.5** 18 ± 4 3 
α1-I225C/V280C 496 ± 41****  0.7 ± 0.1**** 1.4 ± 0.9** 4 
Before DTT 
α1-K276C 3047 ± 843**** 0.9 ± 0.0**** 1.0 ± 0.1** 4 
α1-Q226E/K276C 565 ± 30 1.6 ± 0.1**** 3 ± 1** 5 
α1-K276C/V280M 90 ± 10 1.7 ± 0.2**** 9 ± 2 5 
After DTT 
α1-K276C 4530 ± 
1362**** 1.1 ± 0.1**** 7 ± 3* 5 
α1-Q226E/K276C 525 ± 77 1.8 ± 0.2**** 1.0 ± 0.1** 5 
α1-K276C/V280M 144 ± 20 1.1 ± 0.1**** 9 ± 2 5 
* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 relative to wild type α1 GlyR via one way ANOVA 
followed by Dunnett’s post-hoc test. 
% Results for the wild type α1 GlyR were reproduced from (18). 
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Table 2. Properties of wild type and indicated mutant α1  GlyRs using voltage-clamp fluorometry.  
  
 
Before MTSR labeling 
EC50  
(µM) nH 
Imax  
(µA) n 
α1-R271C 6314 ± 336 1.7 ± 0.0 2.8 ± 0.1 5 
α1-Q226E/R271C 1712 ± 206**** 1.2 ± 0.1* 1.6 ± 0.3 5 
α1-R271C/V280M 12 ± 0**** 2.2 ± 0.1* 5.0 ± 0.6** 5 
 After MTSR labeling 
 EC50  
(µM) nH 
Imax  
(µA) n 
α1-R271C 1202 ± 83 1.7 ± 0.1 3.9 ± 0.5 6 
α1-Q226E/R271C 617 ± 40**** 1.8 ± 0.1 2.1 ± 0.2** 7 
α1-R271C/V280M 2 ± 0**** 1.6 ± 0.2 1.3 ± 0.2**** 6 
 EC50  
(µM) nH 
Fmax  
(%) n 
α1-R271C 977 ± 128 1.6 ± 0.1 6.0 ± 0.7 6 
α1-Q226E/R271C 1097 ± 176 1.1 ± 0.1* 0.7 ± 0.1**** 7 
α1-R271C/V280M 6 ± 1*** 1.6 ± 0.1 2.1 ± 0.4**** 6 
* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 relative to R271C mutant α1 GlyR via one way 
ANOVA followed by Dunnett’s post-hoc test. 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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